Loading...
ArcBest Corp (ARCB) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock has shown a recent decline in price, and its financial performance in the latest quarter is weak. While there are some positive catalysts like insider buying and potential for price recovery based on historical patterns, the lack of strong trading signals, neutral hedge fund sentiment, and weak financials suggest holding off for now.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 46.524, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 99.104, with key resistance at 111.806 and support at 86.403. However, the recent price drop of -4.19% in regular trading and -1.55% post-market indicates short-term weakness.

Insiders are buying, with a significant increase of 284.68% in buying activity over the last month. Analyst price targets have been raised by multiple firms, with some seeing meaningful upside potential if mid-term targets are met. Historical candlestick patterns suggest an 80% chance of a 24.22% increase in the next month.
The company's Q4 financial performance was poor, with revenue, net income, and EPS all showing significant declines. Hedge funds are neutral, and there is no recent congress trading data to indicate influential interest. The stock has no strong trading signals from AI Stock Picker or SwingMax.
In Q4 2025, ArcBest's revenue dropped by -2.89% YoY to $972.7M. Net income fell sharply to -$8.1M, down -127.95% YoY, and EPS dropped to -$0.36, a decline of -129.27% YoY. Gross margin also decreased slightly by -2.30% YoY to 80.83.
Analyst sentiment is mixed. Recent ratings include several price target increases, with targets ranging from $81 to $105. However, many analysts maintain neutral ratings, citing noise in recent trends and weaker-than-expected Q4 results. Some see potential upside if the company meets its mid-term targets.